V021-5353 Screening compound: N-({[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide

V021-5353 Screening compound: N-({[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide
V021-5353 Screening compound: N-({[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V021-5353
N-({[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V021-5353

Molecular Formula

C26H32N4O5 (C26 H32 N4 O5)

Compound Name

N-({[1,4-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide

IUPAC name

N-({[14-bis(4-methoxyphenyl)-1H-imidazol-2-yl]carbamoyl}methyl)-N-(2-methoxyethyl)-2-methylpropanamide

SMILES

CC(C)C(N(CCOC)CC(Nc1nc(-c(cc2)ccc2OC)cn1-c(cc1)ccc1OC)=O)=O

InChI

InChI=1S/C26H32N4O5/c1-18(2)25(32)29(14-15-33-3)17-24(31)28-26-27-23(19-6-10-21(34-4)11-7-19)16-30(26)20-8-12-22(35-5)13-9-20/h6-13,16,18H,14-15,17H2,1-5H3,(H,27,28,31)

InChI Key

ZGZHTADYIYFXQD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19826341

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

480.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.099

Distribution Coefficient, logD

4.099

Water Solubility, LogSw

-4.00

Polar Surface Area

76.344

Acid Dissociation Constant (pKa)

12.87

Base Dissociation Constant (pKb)

2.50

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V021-5353 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V021-5353 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V021-5353?
Check Price and Availability of V021-5353, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V021-5353 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V021-5353
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V021-5353
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V021-5353 available by request